DrugPatentWatch Database Preview
Drugs in Development Information for HSK3486
» See Plans and Pricing
What is the development status for investigational drug HSK3486?
HSK3486 is an investigational drug.
There have been 23 clinical trials for HSK3486.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 20th 2020.
The most common disease conditions in clinical trials are Renal Insufficiency, Liver Diseases, and Renal Insufficiency, Chronic. The leading clinical trial sponsors are Sichuan Haisco Pharmaceutical Group Co., Ltd., Haisco Pharmaceutical Group Co., Ltd., and First Hospital of Jilin University.
There is one US patent protecting this investigational drug and twenty international patents.
Summary for HSK3486
| US Patents | 1 |
| International Patents | 20 |
| US Patent Applications | 2 |
| WIPO Patent Applications | 11 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2020-11-20) |
| Vendors | 3 |
Recent Clinical Trials for HSK3486
| Title | Sponsor | Phase |
|---|---|---|
| A Clinical Study Evaluating Sedation of Intravenous Administration of HSK3486 in ICU Patients Undergoing Long-Term Mechanical Ventilation | Haisco Pharmaceutical Group Co., Ltd. | Phase 2 |
| A Study to Evaluate the Efficacy and Safety of HSK3486 in the Induction of General Anesthesia | Sichuan Haisco Pharmaceutical Group Co., Ltd. | Phase 3 |
| A Study Evaluating Sedation of Intravenous Administration of HSK3486 Injectable Emulsion in ICU Patients Undergoing Mechanical Ventilation | Haisco Pharmaceutical Group Co., Ltd. | Phase 3 |
Clinical Trial Summary for HSK3486
Top disease conditions for HSK3486
Top clinical trial sponsors for HSK3486
US Patents for HSK3486
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| HSK3486 | Start Trial | Phenol derivative and preparation method and use in medicine thereof | Sichuan Haisco Pharmaceutical Co., Ltd. (Chengdu, CN) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for HSK3486
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| HSK3486 | Australia | AU2014264103 | 2033-05-09 | Start Trial |
| HSK3486 | Brazil | BR112015028212 | 2033-05-09 | Start Trial |
| HSK3486 | Canada | CA2911845 | 2033-05-09 | Start Trial |
| HSK3486 | China | CN104507899 | 2033-05-09 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
